Clearside Biomedical, Inc.CLSDNASDAQ
Loading
Debt Growth Recovery in ProgressRecovering
Percentile Rank13
Year-over-Year Change
Year-over-year debt growth rate
Percentile
P13
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | -16.32% |
| Q2 2025 | -99.01% |
| Q1 2025 | 3.03% |
| Q4 2024 | 5.00% |
| Q3 2024 | 5.00% |
| Q2 2024 | 4.99% |
| Q1 2024 | 5.42% |
| Q4 2023 | 3859.58% |
| Q3 2023 | -5.97% |
| Q2 2023 | -5.56% |
| Q1 2023 | -96.53% |
| Q4 2022 | 9.03% |
| Q3 2022 | 6368.40% |
| Q2 2022 | -15.40% |
| Q1 2022 | -12.44% |
| Q4 2021 | -10.95% |
| Q3 2021 | -9.55% |
| Q2 2021 | -8.52% |
| Q1 2021 | -53.74% |
| Q4 2020 | -3.41% |
| Q3 2020 | -3.26% |
| Q2 2020 | -66.78% |
| Q1 2020 | -0.48% |
| Q4 2019 | -44.78% |
| Q3 2019 | -0.27% |
| Q2 2019 | -4.32% |
| Q1 2019 | 21.94% |
| Q4 2018 | 0.65% |
| Q3 2018 | 0.64% |
| Q2 2018 | 34.77% |
| Q1 2018 | -8.77% |
| Q4 2017 | 1.34% |
| Q3 2017 | 1.37% |
| Q2 2017 | 1.37% |
| Q1 2017 | 1.38% |
| Q4 2016 | 1.30% |
| Q3 2016 | 31.71% |
| Q2 2016 | -5.78% |
| Q1 2016 | 0.99% |
| Q4 2015 | 1.03% |